NEW YORK ( TheStreet) -- Santarus (Nasdaq: SNTS) hit a new 52-week high Tuesday as it is currently trading at $6.63, above its previous 52-week high of $6.60 with 616,161 shares traded as of 11:15 a.m. ET. Average volume has been 428,400 shares over the past 30 days. Santarus has a market cap of $375.1 million and is part of the health care sector and drugs industry. Shares are up 81% year to date as of the close of trading on Friday. Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company has a P/E ratio of 66.6, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter